According to the research report titled ‘Rhinoplasty Implants Market Size By Procedure (Surgical {Open Rhinoplasty, Closed Rhinoplasty}, Non-surgical), By Gender (Female, Male), By End-use (Hospitals, Ambulatory Surgical Centers), COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, global rhinoplasty implants market is expected to amass notable gains by the year 2027.
 

Availability of affordable cosmetic surgeries coupled with growing cognizance regarding aesthetic appeal are some of the key factors driving the growth of global rhinoplasty implants market. It is worth noting that there has been an increase in number of cosmetic procedures to enhance their facial features, which in turn has impelled the growth of cosmetic surgery sector.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3976588/

Non-surgical rhinoplasty procedures are known to effectively hide minor improvements, such as high a bump on the face, make the nose narrower, or add dorsal height. Surgical procedures are mostly used for fixing functional nasal issues including deviated septum.

Based on procedure type, the report cites that the non-surgical segment had generated USD 480 million in the year 2020 and is predicted to expand at 16.1% CAGR through 2027. Easy accessibility to dermal fillers and high efficiency offered by non-surgical rhinoplasty implants are fueling the segmental size.

Moving on the gender type, global rhinoplasty implants industry share from the female segment had reached USD 585 million in 2020 and is likely to register 16.1% CAGR during 2021-2027. This can be attributed to the rising cognizance regarding nose reshaping procedures.

Citing the end-user landscape, the ambulatory surgical centers accounted for USD 291 million in 2020 and is anticipated to showcase 15.9% CAGR through 2027. Technological breakthroughs in aesthetic procedures has allowed for availability of low-cost treatment options in ambulatory surgical centers, which in turns is facilitating the business scenario.

Considering the geographical landscape, the report claims that rhinoplasty implants market value in Middle East & Africa exceeded USD 39 million in 2020 and will record 14.4% CAGR over the period of 2021-2020. This is largely due to growing beauty conscious population in the region.

The major companies operating in global rhinoplasty implants market are Sinclair Pharma plc, Prollenium Medical Technologies Inc., Croma-Pharma GmbH, Luminera, Anika Therapeutics Inc., Galderma S.A., W. L. Gore & Associates Inc., Stryker Corp., Wanhe Plastic Materials Co. Ltd., Surgiform Technologies Ltd., Koken Co. Ltd., and Implantech among others.